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Abstract
Multiple cutaneous and uterine leiomyomatosis (MCUL), also known as Reed's syndrome, is a rare
genodermatosis, with an autosomal dominant pattern of inheritance. It results from a germline
heterozygous mutation of fumarate hydratase gene, that is classified as a tumor suppressor gene.
Hereditary leiomyomatosis and renal cell cancer is characterized by the association of MCUL with renal
cell carcinoma. We report a case of a 57-year-old woman, with multiple cutaneous leiomyomas as the
presenting sign of Reed's syndrome.
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What was known?
Reed's syndrome is a rare genodermatosis characterized by multiple cutaneous leiomyomas and uterine
leiomyomas in women. When presenting with renal cell carcinoma, it is labeled as hereditary
leiomyomatosis and renal cell cancer.
Introduction
Reed's syndrome is a genodermatosis reported in approximately 200 families worldwide.[1] In both,
multiple cutaneous and uterine leiomyomatosis (MCUL), and hereditary leiomyomatosis and renal cell
cancer (HLRCC), successive generations develop leiomyomas through an autosomal dominant pattern of
inheritance.[2] They result from a germline heterozygous mutation of fumarate hydratase (FH) gene on
chromosome 1q42.3–q43. FH gene encodes the fumarate enzyme, which converts fumarate to malate in
the Krebs cycle.[3]
Case Report
A 57-year-old woman presented with a 10-year history of multiple skin lesions, intermittently painful,
especially with cold and pressure. Physical examination revealed multiple erythematous-to-brownish
papules and nodules, with a smooth surface, grouped in the upper back [Figure 1]. The patient's past
medical history was significant for a hysterectomy, due to uterine leiomyomas, 11 years ago. Concerning
family history, she had a sister with both skin and uterine leiomyomas. A biopsy of a papule from her back
was taken, and the histological examination revealed a leiomyoma [Figure 2]. Immunohistochemistry
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Clinical and histological findings combined with surgical and family history suggested Reed's syndrome,
and a genetic test was conducted. The result was a heterozygous deletion of FH exon, confirming the
diagnosis of Reed's syndrome.
Given this, the patient underwent tomographic examination, which showed multiple renal cysts, the largest
with 17 mm diameter, located on the middle third of the left kidney. No evidence of renal carcinoma was
found. The patient was medicated with oral nifedipine and topical capsaicin, resulting in symptomatic
improvement.
Patient's sister and daughter were also referred to genetic testing and counseling.
Discussion
MCUL is a rare syndrome, with characteristic clinical expressions. Cutaneous leiomyomas are often the
first manifestation of the disease, presenting at a median age of 25 years, but the majority appear at the age
of 40.[4] They appear as skin-colored or pink-brown papules or nodules, often associated with pain and
paresthesias.[5] These lesions are usually located in the trunk, extremities, and occasionally in the face and
tend to increase in number and dimension with aging. A pseudo Darier sign may occur, which is a transient
piloerection or elevation of the lesion induced by rubbing.[6] Although it is rare, leiomyomas can
degenerate into leiomyosarcomas.[7] Treatment of leiomyomas depends on the number, extension, and
symptomatology. For single and small lesions, surgical excision is an option, but camouflaging the area
and avoiding exposure to cold may be sufficient. For extensive and more symptomatic cases, treatment
with calcium-channel blockers such as nifedipine, alpha-adrenergic-blocking agents, or gabapentin can be
tried. Destructive therapies such as cryotherapy, electrodessication, and carbon dioxide laser ablation may
also be employed.[8]
Uterine leiomyomas are present in almost all women at a median age of 30 year and can cause
dysmenorrhea, menstrual irregularities, and menorraghias. Concerns about fertility emphasize the
importance of an early diagnosis, allowing a proper counseling to female patients.[9]
In HLRCC, renal tumors are usually aggressive, occurring in 15% of the cases, at a median age of 44 year.
Papillary type 2 renal cell carcinoma is the most frequent subtype. The patient can be asymptomatic or can
complain about lumbar pain and hematuria. Annual renal imaging should be recommended, and the
modalities of choice are magnetic resonance imaging and/or computerized tomography.[8]
It is noteworthy that the incidence of benign renal cysts is high in HLRCC patients (36%), compared to the
general population (4.6%–8.2%).[10]
Conclusion
When a patient presents with cutaneous leiomyomas, it is important to perform a complete history,
including family and surgical antecedents, and physical examination. If Reed's syndrome is suspected,
female patients should be referred to gynecologist. As uterine leiomyomas can reduce fertility, this strategy
allows for early family planning. Genetic testing and counseling should also be offered, including family
members. All the patients should be screened for renal cell carcinoma every 12 months to anticipate the
detection and treatment of renal cell carcinoma.[8]
This case highlights the importance of skin lesions as a diagnostic clue for systemic diseases. It is essential
to recall the correlation between these cutaneous lesions and renal cell carcinoma, to identify individuals
with HLRCC early. A prompt diagnosis enables the genetic counseling of the patient and his relatives,
through a multidisciplinary approach, allowing the early detection of the underlying malignancies - renal
cell carcinoma and leiomyosarcoma.
Considering previous reports, Reed's syndrome also seems to be associated with benign renal cysts.
Further research is needed to determine whether this association is coincidental or not and if it be, it may
be a predisposing factor to renal cell carcinoma.
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What is new?
Patients with Reed1s syndrome may be predisposed to develop renal cysts.
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